Ligand Pharmaceuticals Inc.
3911 Sorrento Valley Boulevard
Suite 110
San Diego
California
92121
United States
Tel: 858-550-7500
Website: http://www.ligand.com/
Email: investors@ligand.com
547 articles about Ligand Pharmaceuticals Inc.
-
Ligand Pharmaceuticals Inc. Announces Third Quarter Results
11/7/2008
-
Ligand Pharmaceuticals Inc. and Pharmacopeia, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
11/4/2008
-
Ligand Pharmaceuticals Inc. to Hold Third Quarter Results Conference Call on November 6
10/29/2008
-
Ligand Pharmaceuticals Inc. and Pharmacopeia, Inc. to Present At the Oppenheimer 19th Annual Healthcare Conference
10/29/2008
-
Ligand Pharmaceuticals Inc. to Acquire Pharmacopeia, Inc. for Stock and Contingent Value Rights for $70M
9/25/2008
-
Ligand Pharmaceuticals Inc. and the Salk Institute for Biological Studies Enter Settlement Agreement and Mutual Release of All Claims
9/5/2008
-
Ligand Pharmaceuticals Inc. Appoints Dr. Stephen Sabba to Board of Directors
8/5/2008
-
Ligand Pharmaceuticals Inc. Announces Second Quarter Results
8/1/2008
-
Ligand Pharmaceuticals Inc. to Hold Second Quarter Results Conference Call on July 31
7/21/2008
-
Ligand Pharmaceuticals Inc. to Present at the Needham & Company Biotechnology and Medical Technology Conference on June 11
6/4/2008
-
GlaxoSmithKline and Ligand Pharmaceuticals Inc. Promacta(R) (Eltrombopag) Receives Unanimous Recommendation By FDA Advisory Panel
6/2/2008
-
Ligand Pharmaceuticals Inc. Announces First Quarter Results
5/2/2008
-
Ligand Pharmaceuticals Inc. Initiates Phase II Trial with LGD-4665 in Idiopathic Thrombocytopenic Purpura
4/24/2008
-
Ligand Pharmaceuticals Inc. to Hold First Quarter Results Conference Call on May 1
4/22/2008
-
Ligand Pharmaceuticals Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
2/21/2008
-
Ligand Pharmaceuticals Inc. to Hold Fourth Quarter Results Conference Call on February 20
2/13/2008
-
Ligand Pharmaceuticals Inc. to Present at Biotechnology Industry Organization (BIO) CEO and Investor Conference on February 12
2/5/2008
-
Ligand Pharmaceuticals Inc. Partner Pfizer Inc. Submits NDA for Fablyn(R)
1/15/2008
-
Ligand Pharmaceuticals Inc. Awarded U.S. Patent for LGD-4665
1/8/2008
-
Ligand Pharmaceuticals Inc. Earns $1 Million Milestone Payment as GlaxoSmithKline Submits New Drug Application for PROMACTA(R) (eltrombopag)
12/20/2007